Cresco Labs schedules November 6 results for Cresco Labs stock

Published on 10/20/2026 at 18:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cresco Labs posts USD 173.34 million Q2 revenue, up 15.00 percent sequentially. Cresco Labs stock costs EUR 0.55 at Lang & Schwarz on October 20, 2026.

Reporting date November 6, 2026

Cresco Labs will report third-quarter results on November 6, 2026.
Second-quarter revenue reached USD 173.34 million, up 15.00 percent sequentially, while adjusted EBITDA was USD 40.00 million.
Cresco Labs stock costs EUR 0.55 at Lang & Schwarz on October 20, 2026 at 6:30 p.m. CEST.

CL, CA22587M1068, Illustration mit AI erstellt.

Cresco Labs (ISIN CA22587M1068) is scheduled to report its third-quarter 2026 results on November 6, 2026, before the US market opens, according to StockTitan. The stock costs EUR 0.55 at Lang & Schwarz on October 20, 2026 at 6:30 p.m. CEST.

Second-quarter growth reached 15.00 percent

Cresco Labs reported USD 173.34 million in revenue for the second quarter ended June 30, 2026, up 15.00 percent sequentially. Adjusted gross profit was USD 89.00 million, equal to a 52.00 percent margin, while adjusted EBITDA reached USD 40.00 million, or 23.00 percent of revenue, according to Benzinga. Operating cash flow was USD 15.00 million in the same quarter, compared with a use of USD 6.00 million in the first quarter.

Canadian quote remains near yearly low

On the Canadian Securities Exchange, CL.CN was at CAD 0.85 on October 20, 2026 at 12:23 p.m. ET, up 3.66 percent from CAD 0.82. The same quote places the 52-week range at CAD 0.81 to CAD 3.12, leaving the stock close to its yearly low. Market capitalization was CAD 301.0 million as of October 20, 2026.

November date sets the next checkpoint

The November 6 report will cover the quarter ended September 30, 2026. The company operates branded cannabis products and Sunnyside dispensaries across regulated US markets, according to its investor-relations overview. The upcoming release gives investors a defined checkpoint for revenue, adjusted EBITDA and cash generation after the second-quarter improvement.

What the next report will test

The second-quarter figures showed revenue growth alongside stronger cash generation, but the next release will test whether that combination held through the third quarter. Management previously discussed continued expansion in Pennsylvania, Ohio and Kentucky, while also pointing to pricing pressure and competition in its outlook.

Stock price and reporting date

Cresco Labs stock costs EUR 0.55 at Lang & Schwarz on October 20, 2026 at 6:30 p.m. CEST. The Canadian Securities Exchange quote was CAD 0.85 at 12:23 p.m. ET on the same date, and the company is scheduled to report third-quarter results on November 6, 2026.

The further course of trading is shown by the continuously updated real-time quote of Cresco Labs stock.